Samsung Biologics released a promoter-optimized mini helper plasmid that boosts AAV manufacturing yield.
Published
Signal category
Products & Services
Quote
“a promoter-optimized mini helper plasmid that boosts AAV manufacturing yield”
— Samsung Biologics team
Company
Samsung Biologics
Innovation, passion and an unwavering dedication to find breakthrough solutions in biomedicines.
- Industry
- Pharmaceutical Manufacturing
- Location
- Songdo, KR
- Company size
- 2,551 employees
Samsung Biologics is a fully integrated CDMO offering state-of-the-art contract development and manufacturing services. With proven regulatory approvals, the largest capacity, and the fastest throughput, Samsung Biologics is an award-winning partner of choice and is uniquely able to support the development and manufacturing of biologics products at every stage of the process while meeting the evolving needs of biopharmaceutical companies worldwide.
Founded 2011